Skip to main content
. 2015 Sep-Oct;19(5):633–638. doi: 10.4103/2230-8210.163183

Figure 3.

Figure 3

Comparison of 3-methoxytyramine values in different groups using scatter plot Groups (0-control, 1-head and neck paragangliomas, 2-pheochromocytomas and paragangliomas [PHEO/PGL], 3-benign PHEO/PGL, 4-malignant pheochromocytomas/paragangliomas). In this scatter plot the 3-methoxytyramine levels were compared between different groups